EP4093677A1 - Container for a pharmaceutical product - Google Patents

Container for a pharmaceutical product

Info

Publication number
EP4093677A1
EP4093677A1 EP21701597.3A EP21701597A EP4093677A1 EP 4093677 A1 EP4093677 A1 EP 4093677A1 EP 21701597 A EP21701597 A EP 21701597A EP 4093677 A1 EP4093677 A1 EP 4093677A1
Authority
EP
European Patent Office
Prior art keywords
container
face
casing
constrained
opening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21701597.3A
Other languages
German (de)
French (fr)
Inventor
Enrico LEVA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eurpack Giustini Sacchetti Srl
Original Assignee
Eurpack Giustini Sacchetti Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurpack Giustini Sacchetti Srl filed Critical Eurpack Giustini Sacchetti Srl
Publication of EP4093677A1 publication Critical patent/EP4093677A1/en
Pending legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D5/00Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
    • B65D5/42Details of containers or of foldable or erectable container blanks
    • B65D5/64Lids
    • B65D5/66Hinged lids
    • B65D5/6602Hinged lids formed by folding one or more extensions hinged to the upper edge of a tubular container body
    • B65D5/6608Hinged lids formed by folding one or more extensions hinged to the upper edge of a tubular container body the lid being held in closed position by self-locking integral flaps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D5/00Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper
    • B65D5/02Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper by folding or erecting a single blank to form a tubular body with or without subsequent folding operations, or the addition of separate elements, to close the ends of the body
    • B65D5/0254Rigid or semi-rigid containers of polygonal cross-section, e.g. boxes, cartons or trays, formed by folding or erecting one or more blanks made of paper by folding or erecting a single blank to form a tubular body with or without subsequent folding operations, or the addition of separate elements, to close the ends of the body with end closures formed by inward folding of flaps and securing them by means of a tongue integral with one of the flaps
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D2401/00Tamper-indicating means

Definitions

  • the present invention relates to a container for a pharmaceutical product of the type specified in the preamble of the first claim.
  • the present invention relates to a secondary container, or rather intended to contain a pharmaceutical product which can at the same time already contain primary containers such as blisters or vials.
  • packaging for pharmaceutical products substantially comprises at least one primary container and one secondary container.
  • the primary container is preferably capable of directly containing the pharmaceutical product, whether solid or liquid, and can therefore consist of a peelable sheet defining a plurality of capsules, such as common blisters, or a vial, for example for containing liquid substances.
  • the secondary containers are capable of containing one or more primary containers.
  • the secondary containers substantially define a box-like shape that can be opened and closed with simplicity, usually in the shape of a rectangular parallelepiped and made of material such as paper.
  • Such secondary containers therefore define foldable faces comprising flaps configured to be constrained within specific slots or placed on another face, so as to make the secondary container.
  • the conventional secondary containers do not allow to distinguish in a clear and immediately evident way whether the box has already been opened and closed. Therefore, substantially, the containers of the known art do not respond, in a sufficient way, to the new anti-tampering standards, and for this reason they are now hardly usable and not suitable for containing, in a correct manner, the pharmaceutical product inside.
  • the technical task underlying the present invention is to devise a container for a pharmaceutical product capable of substantially obviating at least part of the aforementioned drawbacks.
  • Another important aim of the invention is to provide a container which meets the aforementioned needs while maintaining a discrete manufacturing simplicity and economy.
  • the Fig. 1 shows a perspective view of a container for pharmaceutical product according to the invention wherein the cover is open and the closure system of the container is evident; and the Fig. 2 illustrates a view in section perpendicular to the main axis of a container for pharmaceutical product according to the invention assembled wherein it is evident the spiral shape with which the flat elements are coupled by the means of the portion of the bonding and the fixing portion and, moreover, the way in which the flap protrudes through the second hole in the secondary wall is also evident; and the Fig. 3 is a plan view of the pre-assembly silhouette of a container for pharmaceutical product according to the invention.
  • the measurements, values, shapes and geometric references (such as perpendicularity and parallelism), when associated with words like “about” or other similar terms such as “approximately” or “substantially”, are to be considered as except for measurement errors or inaccuracies due to production and/or manufacturing errors, and, above all, except for a slight divergence from the value, measurements, shape, or geometric reference with which it is associated.
  • these terms if associated with a value, preferably indicate a divergence of not more than 10% of the value.
  • the container for pharmaceutical product according to the invention is globally indicated with the number 1.
  • the container 1 is configured to prevent or signal its tampering. Furthermore, the container 1 is preferably capable of allowing the housing of delicate products such as pharmaceutical products, as already indicated, but could be used to house any other object.
  • the container 1 comprises a casing 2.
  • the casing 2 is substantially a box-like element defining at least one housing space.
  • the casing 2 can have a conventional shape, for example a parallelepiped with a rectangular base, or it can have particular shapes, for example a parallelepiped with a polygonal base, or it can also be cylindrical and have a round base.
  • the casing 2 therefore, includes one or more faces 20.
  • the casing 2 is cylindrical, it substantially includes only one face 20, or if it is parallelepiped with a rectangular base, it comprises four faces 20.
  • the face or faces 20 define, in any case, a containment volume. In other words, the face or faces 20 delimit the containment volume.
  • the containment volume can therefore be closed or accessible from the outside.
  • the casing 2 comprises at least one opening 21.
  • the opening 21 is capable of allowing the access to the containment volume from the outside.
  • the opening 21 can be included in a base and can also be extended as the whole of the base.
  • the casing 2 moreover, can include two openings 21.
  • the two openings 21 are arranged in correspondence with opposite sides of the casing 2.
  • the casing 2 advantageously also includes at least one secondary face 22.
  • the secondary face 22 is preferably overlapping, within the containment volume, to a portion of the first face 20.
  • the secondary face 22 and the first face 20 define an overlapping area
  • the overlapping area 23 is substantially the area on which the faces 22, 20 mutually face each other. Therefore, it extends, at least, as the less extended face between the first face 20 and the second face 22.
  • the overlapping zone extends substantially as the extension area of the faces 20, 22.
  • the secondary face 22 and the first face 20 define a slot 24.
  • the slot 24 is substantially the portion of space including the faces 20, 22. Therefore it is arranged between the faces 20, 22.
  • the faces 20, 22 are preferably, but not necessarily, facing each other in such a way as to be parallel between them. Therefore, in this configuration, the slot 24 also extends parallel to the faces 20, 22. The thickness of the slot 24 is therefore substantially defined by the distance between the faces 20, 22.
  • the container 1 therefore comprises at least one lid 3.
  • the lid 3 is preferably configured to close the opening 21.
  • the container 1 when the container 1 includes a greater number of openings 21 , for example two, the container preferably includes a number of lids 3 equal to the openings 21. In the case where the there are two openings 21 , the container 1 comprises two lids 3. If the openings 21 are arranged in correspondence of opposite sides of the casing 2, also the lids 3 are.
  • the lid 3 closes the opening 21 in at least one closing configuration.
  • the lid 3, moreover, preferably includes a first portion 30 and a second portion 31.
  • the first portion 30 is preferably constrained to the casing 2.
  • the first portion 30 can therefore be a flat element separated from the casing 2 by creases that allow the fold of the first portion 30 with respect to the casing 2 itself. Furthermore, the first portion 30 is capable of overlapping the opening 21. Therefore, substantially, the first portion 30 extends substantially like the opening 21.
  • the second portion 31 is, on the other hand, configured to be housed within the slot 24.
  • the second portion 31 is also capable of overlapping at least partially to the overlapping area 23, when the container 1 is in the closed configuration.
  • the second portion 31 is capable of being situated between the faces 20, 22 in correspondence with the overlapping area 23.
  • the slot 24 preferably defines a thickness capable of allowing the insertion of the second portion 31 .
  • the second portion 31 is preferably flat and also defines a thickness.
  • the thickness of the slot 24 is greater than or equal to the thickness of the second portion 31 , preferably close to, but not identical to the thickness of the second portion 31 .
  • connection means 32 are preferably tear-off resolvable. In particular, they are preferably the means that can be resolved manually by a user.
  • connection means 32 therefore preferably comprise one or more first incision lines 32a.
  • the first incision lines 32a are, in particular, preferably dashed. Therefore, the first incision lines 32a have more yielding areas suitable for allowing the second portion 31 to be quickly and easily torn away from the first portion 30.
  • connecting means 32 can also include a second incision 32b.
  • the second incision 32b is preferably a continuous cut capable of defining a separation zone between the first portion 30 and the second portion 31 .
  • the second incision 32b is arranged between two first incision lines 32a.
  • the second incision 32b if present, is in particular preferably configured to form a gripping portion 34.
  • the gripping portion 34 is a small protuberance, defined by the second incision 32b, capable of facilitating the gripping for a user. Therefore, it is capable of allowing the connection means 32 to be quickly resolved.
  • the container 1 also comprises other additional elements.
  • the first wall 20 preferably comprises a flap 25.
  • the flap 25 is preferably overlapping, also itself, apart from the overlapping area 23.
  • the flap 25 protrudes skew with respect to the first face 20.
  • the flap 25 protrudes away from the opening 21.
  • the flap 25 is oriented in such a way that the free end is facing the inside of the casing 2.
  • the flap 25, therefore, can substantially protrude from the first face 20 toward the secondary face 21 and can also go to contact with the secondary face 21 . Therefore, the secondary face 21 can block the free end of the flap 25, or the secondary face 22 can comprise a second hole 22a.
  • the second hole 22a overlaps at least part of the flap 25. Furthermore, the second hole 22a is configured to allow the flap 25 to protrude at least partially through the second hole 22a.
  • the second portion 31 preferably comprises a first hole 33.
  • the first hole 33 is configured to interlock the flap 25 when the lid 3 is in the closed configuration.
  • the second portion 31 is irreversibly blocked by means of the first hole 33 and the flap 25. Even more in detail, the second portion 31 is blocked in correspondence with the overlapping area 23.
  • connection means 32 Therefore, once the lid 3 has been arranged in the configuration of closure a first time, access to the containment volume is allowed exclusively by resolving the connection means 32.
  • the container 1 provides an anti-tampering closure.
  • the container 1 in a preferred embodiment, defines a conventional external form. Therefore, it preferably defines a rectangular parallelepiped shape wherein the lids 3, preferably two in number, define the bases of the parallelepiped and the first faces 20, preferably four in number, define the lateral surface of the parallelepiped.
  • the container 1 is made starting from a contour 4.
  • the contour 4, shown in Fig. 3, is preferably in one piece.
  • the main axis 1a is the axis around which the first faces 20 develop, as clearly shown in Fig. 2.
  • the longitudinal axis 1 b is preferably perpendicular to the main axis 1a.
  • the contour 4 preferably comprises at least four flat elements 40.
  • the flat elements 40 preferably have a substantially rectangular shape.
  • the flat elements 40 are preferably constrained in succession along the longitudinal axis 1 b. With the term “succession” it is intended that each flat element 40 can be exclusively adjacent to only one or a maximum of two flat elements 40. If a flat element 40 is adjacent to two flat elements 40, it is substantially arranged between the two flat elements 40.
  • the flat elements 40 are configured to achieve the casing 2 when reclosed, during assembly, around the main axis 1a.
  • the flat elements 40 can be separated from each other by creases which simplify the folding of the various flat elements 40.
  • the flat elements 40 therefore substantially define the first faces 21 .
  • the contour 4 also comprises two fins 41.
  • the fins 41 are preferably constrained to one of the flat elements 40.
  • the fins 41 are constrained on opposite sides, with respect to the main axis 1a, of the flat element 40 on which they are constrained.
  • the fins 41 substantially define the lids 3 when the contour 4 is in the assembly phase.
  • contour 4 also comprises, in correspondence of a free end along the longitudinal axis 1a, a second flat element 42.
  • the second flat element 42 is preferably configured to form the secondary face 22 when in the assembly configuration.
  • the second flat element 42 could be separated from the rest of the contour 4, however, preferably, the second flat element 42 is preferably connected to the first flat elements 40.
  • the second flat element 42 is not directly connected to a first flat element 40, but is connected by means of an intermediate element.
  • the contour 4 in fact also comprises a bonding portion 43.
  • the bonding portion 43 is the aforementioned intermediate element.
  • the bonding portion 43 is arranged between the second flat element 42 and one of the first flat elements 40. Furthermore, the bonding portion 43 is configured to be glued to one of the first flat elements 40 defining a constraint area. Basically, the bonding portion 43 is the portion which allows the first flat elements 40 to be closed in a stable manner, making the casing 2.
  • the bonding portion 43 is substantially capable of adhering in whole or in part with all or part of a first flat element 40.
  • the bonding portion 43 has a smaller extension than the first flat element 40 on which it is constrained in such a way that the first flat elements 40, the bonding portion 43 and the second flat element 42 define, when assembled, a substantially spiral section perpendicular to the main axis 1a.
  • the spiral section is shown, in particular, in Fig. 2.
  • the contour 4 can, therefore, also include a fixing portion 44.
  • the fixing portion 44 is disposed adjacent to the free end of the second flat element 42.
  • the fixing portion 44 is configured to be glued to a first flat element 40 on a side opposite the bonding portion 43 in such a way that forms the slot 24.
  • the shape 4 can include auxiliary fins 45.
  • the auxiliary fins 45 are substantially similar to the lateral closing fins present in any container of the known art.
  • a user can fold the contour 4, during the assembly phase, by gluing the bonding portion 43 and the fixing portion 44 to the respective first flat elements 40 in such a way as to define, in the first instance, a container in an open configuration.
  • the fins 41 can be folded over the opening 21 and the first portions 31 of the lids 3 can be inserted into the respective slots 24.
  • the lids 3 and the container 1 When the first portions 31 are pushed inside the slots 24 in such a way as to overlap the overlapping area 23 and in such a way that the flaps 25 are trapped in the respective first holes 33, the lids 3 and the container 1 generally provide the closing configuration.
  • the container for pharmaceutical product 1 according to the invention achieves important advantages.
  • the container 1 responds to the new anti-tampering regulations and makes it possible to clearly indicate whether the container 1 has already been opened or not.
  • the preceding advantage is obtained thanks to a contour wherein there is substantially only one main gluing point or, at most, two gluing points.
  • the container 1 maintains a significant manufacturing simplicity and consequent cheapness.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Cartons (AREA)
  • Packages (AREA)

Abstract

It is provided a container (1) for pharmaceutical product including a casing (2) comprising one or more first faces (20) defining a containment volume, at least one opening (21) capable of allowing access to the containment volume from the external, at least one secondary face (22) overlapped, within the containment volume, to a portion of the first face (20) in such a way as to define an overlapping area (23) and a slot (24), and at least one lid (3) configured to close the opening (21), in at least one closing configuration, and including at least a first portion (30) constrained to the casing (2) and capable of overlapping the opening (21) and a second portion (31) configured to be housed within the slot (24) and to at least partially overlap the overlapping area (23) in the closure configuration, wherein the portions (30, 31) are mutually constrained by connection means (32) which are tear- off resolvable, the first face (20) comprises at least one flap (25) overlapped on part of the overlapping area (23) and protruding skewed with respect to the first face (20) away from the opening (21), and the second portion (31) comprises a hole (33) configured to house interlocked the tab (25) when the lid (3) is in the closed configuration in such a way as to irreversibly lock the second portion (31) in the overlapping area (23) and allow the access to the containment volume exclusively solving the means of connection (32).

Description

DESCRIPTION
CONTAINER FOR A PHARMACEUTICAL PRODUCT
The present invention relates to a container for a pharmaceutical product of the type specified in the preamble of the first claim.
In particular, the present invention relates to a secondary container, or rather intended to contain a pharmaceutical product which can at the same time already contain primary containers such as blisters or vials.
As is known, packaging for pharmaceutical products substantially comprises at least one primary container and one secondary container. The primary container is preferably capable of directly containing the pharmaceutical product, whether solid or liquid, and can therefore consist of a peelable sheet defining a plurality of capsules, such as common blisters, or a vial, for example for containing liquid substances.
The secondary containers, on the other hand, are capable of containing one or more primary containers.
Generally, the secondary containers substantially define a box-like shape that can be opened and closed with simplicity, usually in the shape of a rectangular parallelepiped and made of material such as paper.
Such secondary containers therefore define foldable faces comprising flaps configured to be constrained within specific slots or placed on another face, so as to make the secondary container.
The known technique described comprises some important drawbacks.
In particular, the conventional secondary containers do not allow to distinguish in a clear and immediately evident way whether the box has already been opened and closed. Therefore, substantially, the containers of the known art do not respond, in a sufficient way, to the new anti-tampering standards, and for this reason they are now hardly usable and not suitable for containing, in a correct manner, the pharmaceutical product inside.
In this situation, the technical task underlying the present invention is to devise a container for a pharmaceutical product capable of substantially obviating at least part of the aforementioned drawbacks.
Within the scope of said technical task, it is an important aim of the invention to obtain a container for a pharmaceutical product which responds to the new anti tampering standards and allows a clear signal to a possible user that the container has already been opened.
Another important aim of the invention is to provide a container which meets the aforementioned needs while maintaining a discrete manufacturing simplicity and economy.
The technical task and the specified aims are achieved by a container for a pharmaceutical product as claimed in the annexed claim 1 .
Preferred technical solutions are highlighted in the dependent claims.
The features and advantages of the invention are clarified below by the detailed description of preferred embodiments of the invention, with reference to the accompanying figures, in which: the Fig. 1 shows a perspective view of a container for pharmaceutical product according to the invention wherein the cover is open and the closure system of the container is evident; and the Fig. 2 illustrates a view in section perpendicular to the main axis of a container for pharmaceutical product according to the invention assembled wherein it is evident the spiral shape with which the flat elements are coupled by the means of the portion of the bonding and the fixing portion and, moreover, the way in which the flap protrudes through the second hole in the secondary wall is also evident; and the Fig. 3 is a plan view of the pre-assembly silhouette of a container for pharmaceutical product according to the invention.
In the present document, the measurements, values, shapes and geometric references (such as perpendicularity and parallelism), when associated with words like “about” or other similar terms such as “approximately” or “substantially”, are to be considered as except for measurement errors or inaccuracies due to production and/or manufacturing errors, and, above all, except for a slight divergence from the value, measurements, shape, or geometric reference with which it is associated. For instance, these terms, if associated with a value, preferably indicate a divergence of not more than 10% of the value.
Moreover, when used, terms such as “first”, “second”, “higher”, “lower”, “main” and “secondary” do not necessarily identify an order, a priority of relationship or a relative position, but can simply be used to clearly distinguish between their different components.
Unless otherwise specified, as results in the following discussions, terms such as “treatment”, “computing”, “determination”, “calculation”, or similar, refer to the action and/or processes of a computer or similar electronic calculation device that manipulates and/or transforms data represented as physical, such as electronic quantities of registers of a computer system and/or memories in, other data similarly represented as physical quantities within computer systems, registers or other storage, transmission or information displaying devices. The measurements and data reported in this text are to be considered, unless otherwise indicated, as performed in the International Standard Atmosphere ICAO (ISO 2533:1975).
With reference to the figures, the container for pharmaceutical product according to the invention is globally indicated with the number 1.
Preferably, the container 1 is configured to prevent or signal its tampering. Furthermore, the container 1 is preferably capable of allowing the housing of delicate products such as pharmaceutical products, as already indicated, but could be used to house any other object.
In this regard, the container 1 comprises a casing 2.
The casing 2 is substantially a box-like element defining at least one housing space. In particular, the casing 2 can have a conventional shape, for example a parallelepiped with a rectangular base, or it can have particular shapes, for example a parallelepiped with a polygonal base, or it can also be cylindrical and have a round base.
The casing 2, therefore, includes one or more faces 20.
For example, if the casing 2 is cylindrical, it substantially includes only one face 20, or if it is parallelepiped with a rectangular base, it comprises four faces 20.
The face or faces 20 define, in any case, a containment volume. In other words, the face or faces 20 delimit the containment volume.
The containment volume can therefore be closed or accessible from the outside. Preferably, the casing 2 comprises at least one opening 21.
The opening 21 is capable of allowing the access to the containment volume from the outside.
If the casing 20 defines, for example, a cylindrical or parallelepiped structure, the opening 21 can be included in a base and can also be extended as the whole of the base.
The casing 2, moreover, can include two openings 21.
If present, preferably, the two openings 21 are arranged in correspondence with opposite sides of the casing 2.
The casing 2 advantageously also includes at least one secondary face 22.
The secondary face 22 is preferably overlapping, within the containment volume, to a portion of the first face 20.
In this way, the secondary face 22 and the first face 20 define an overlapping area
23
The overlapping area 23 is substantially the area on which the faces 22, 20 mutually face each other. Therefore, it extends, at least, as the less extended face between the first face 20 and the second face 22.
If the faces 20, 22 define areas of substantially identical extensions, the overlapping zone extends substantially as the extension area of the faces 20, 22.
Furthermore, the secondary face 22 and the first face 20 define a slot 24.
The slot 24 is substantially the portion of space including the faces 20, 22. Therefore it is arranged between the faces 20, 22.
Furthermore, the faces 20, 22 are preferably, but not necessarily, facing each other in such a way as to be parallel between them. Therefore, in this configuration, the slot 24 also extends parallel to the faces 20, 22. The thickness of the slot 24 is therefore substantially defined by the distance between the faces 20, 22.
The container 1 therefore comprises at least one lid 3.
The lid 3 is preferably configured to close the opening 21.
Naturally, when the container 1 includes a greater number of openings 21 , for example two, the container preferably includes a number of lids 3 equal to the openings 21. In the case where the there are two openings 21 , the container 1 comprises two lids 3. If the openings 21 are arranged in correspondence of opposite sides of the casing 2, also the lids 3 are.
In any case, the lid 3 closes the opening 21 in at least one closing configuration. The lid 3, moreover, preferably includes a first portion 30 and a second portion 31. The first portion 30 is preferably constrained to the casing 2.
The first portion 30 can therefore be a flat element separated from the casing 2 by creases that allow the fold of the first portion 30 with respect to the casing 2 itself. Furthermore, the first portion 30 is capable of overlapping the opening 21. Therefore, substantially, the first portion 30 extends substantially like the opening 21.
The second portion 31 is, on the other hand, configured to be housed within the slot 24.
In in particular, the second portion 31 is also capable of overlapping at least partially to the overlapping area 23, when the container 1 is in the closed configuration. Basically, the second portion 31 is capable of being situated between the faces 20, 22 in correspondence with the overlapping area 23.
Therefore, the slot 24 preferably defines a thickness capable of allowing the insertion of the second portion 31 . The second portion 31 is preferably flat and also defines a thickness. In detail, preferably, the thickness of the slot 24 is greater than or equal to the thickness of the second portion 31 , preferably close to, but not identical to the thickness of the second portion 31 .
The first portion 30 and the second portion 31 are therefore constrained to each other by connection means 32. The connection means 32 are preferably tear-off resolvable. In particular, they are preferably the means that can be resolved manually by a user.
The connection means 32 therefore preferably comprise one or more first incision lines 32a.
The first incision lines 32a are, in particular, preferably dashed. Therefore, the first incision lines 32a have more yielding areas suitable for allowing the second portion 31 to be quickly and easily torn away from the first portion 30.
Furthermore, the connecting means 32 can also include a second incision 32b.
The second incision 32b is preferably a continuous cut capable of defining a separation zone between the first portion 30 and the second portion 31 .
Preferably, the second incision 32b is arranged between two first incision lines 32a. The second incision 32b, if present, is in particular preferably configured to form a gripping portion 34.
The gripping portion 34 is a small protuberance, defined by the second incision 32b, capable of facilitating the gripping for a user. Therefore, it is capable of allowing the connection means 32 to be quickly resolved.
The container 1 also comprises other additional elements.
In particular, the first wall 20 preferably comprises a flap 25.
The flap 25 is preferably overlapping, also itself, apart from the overlapping area 23. In particular, preferably, the flap 25 protrudes skew with respect to the first face 20. Furthermore, the flap 25 protrudes away from the opening 21.
Essentially, the flap 25 is oriented in such a way that the free end is facing the inside of the casing 2.
The flap 25, therefore, can substantially protrude from the first face 20 toward the secondary face 21 and can also go to contact with the secondary face 21 . Therefore, the secondary face 21 can block the free end of the flap 25, or the secondary face 22 can comprise a second hole 22a.
If present, the second hole 22a overlaps at least part of the flap 25. Furthermore, the second hole 22a is configured to allow the flap 25 to protrude at least partially through the second hole 22a.
The presence of the second hole 22a, therefore, is not strictly necessary, but it can increase the efficiency of the flap 25.
The second portion 31 , on the other hand, preferably comprises a first hole 33.
The first hole 33 is configured to interlock the flap 25 when the lid 3 is in the closed configuration.
In particular, the second portion 31 is irreversibly blocked by means of the first hole 33 and the flap 25. Even more in detail, the second portion 31 is blocked in correspondence with the overlapping area 23.
Therefore, once the lid 3 has been arranged in the configuration of closure a first time, access to the containment volume is allowed exclusively by resolving the connection means 32.
In this way, the container 1 provides an anti-tampering closure.
The container 1 , in a preferred embodiment, defines a conventional external form. Therefore, it preferably defines a rectangular parallelepiped shape wherein the lids 3, preferably two in number, define the bases of the parallelepiped and the first faces 20, preferably four in number, define the lateral surface of the parallelepiped.
In this regard, advantageously, the container 1 is made starting from a contour 4. The contour 4, shown in Fig. 3, is preferably in one piece.
It substantially defines a main axis 1a and a longitudinal axis 1b.
The main axis 1a is the axis around which the first faces 20 develop, as clearly shown in Fig. 2.
The longitudinal axis 1 b is preferably perpendicular to the main axis 1a.
The contour 4 preferably comprises at least four flat elements 40.
The flat elements 40 preferably have a substantially rectangular shape.
The flat elements 40 are preferably constrained in succession along the longitudinal axis 1 b. With the term "succession" it is intended that each flat element 40 can be exclusively adjacent to only one or a maximum of two flat elements 40. If a flat element 40 is adjacent to two flat elements 40, it is substantially arranged between the two flat elements 40.
The flat elements 40, therefore, are configured to achieve the casing 2 when reclosed, during assembly, around the main axis 1a.
In this regard, the flat elements 40 can be separated from each other by creases which simplify the folding of the various flat elements 40.
The flat elements 40 therefore substantially define the first faces 21 .
The contour 4 also comprises two fins 41.
The fins 41 are preferably constrained to one of the flat elements 40. In particular, the fins 41 are constrained on opposite sides, with respect to the main axis 1a, of the flat element 40 on which they are constrained.
Furthermore, the fins 41 substantially define the lids 3 when the contour 4 is in the assembly phase.
Naturally, the contour 4 also comprises, in correspondence of a free end along the longitudinal axis 1a, a second flat element 42.
The second flat element 42 is preferably configured to form the secondary face 22 when in the assembly configuration.
Of course, the second flat element 42 could be separated from the rest of the contour 4, however, preferably, the second flat element 42 is preferably connected to the first flat elements 40.
However, the second flat element 42 is not directly connected to a first flat element 40, but is connected by means of an intermediate element.
The contour 4 in fact also comprises a bonding portion 43. The bonding portion 43 is the aforementioned intermediate element.
Therefore, the bonding portion 43 is arranged between the second flat element 42 and one of the first flat elements 40. Furthermore, the bonding portion 43 is configured to be glued to one of the first flat elements 40 defining a constraint area. Basically, the bonding portion 43 is the portion which allows the first flat elements 40 to be closed in a stable manner, making the casing 2.
The bonding portion 43, in detail, is substantially capable of adhering in whole or in part with all or part of a first flat element 40.
Preferably, the bonding portion 43 has a smaller extension than the first flat element 40 on which it is constrained in such a way that the first flat elements 40, the bonding portion 43 and the second flat element 42 define, when assembled, a substantially spiral section perpendicular to the main axis 1a.
The spiral section is shown, in particular, in Fig. 2.
The contour 4 can, therefore, also include a fixing portion 44.
If present, the fixing portion 44 is disposed adjacent to the free end of the second flat element 42.
Furthermore, the fixing portion 44 is configured to be glued to a first flat element 40 on a side opposite the bonding portion 43 in such a way that forms the slot 24.
In conclusion, the shape 4 can include auxiliary fins 45.
The auxiliary fins 45 are substantially similar to the lateral closing fins present in any container of the known art.
The operation of the container for pharmaceutical product according to the invention 1 previously described in structural terms is as follows.
A user can fold the contour 4, during the assembly phase, by gluing the bonding portion 43 and the fixing portion 44 to the respective first flat elements 40 in such a way as to define, in the first instance, a container in an open configuration.
After, for example, the introduction of pharmaceutical products or other objects, the fins 41 , or rather the lids 3, can be folded over the opening 21 and the first portions 31 of the lids 3 can be inserted into the respective slots 24.
When the first portions 31 are pushed inside the slots 24 in such a way as to overlap the overlapping area 23 and in such a way that the flaps 25 are trapped in the respective first holes 33, the lids 3 and the container 1 generally provide the closing configuration.
In order to open the container 1 and access the containment volume, it is therefore necessary to break the lids, or to resolve the connection means 32.
The container for pharmaceutical product 1 according to the invention achieves important advantages.
In fact, the container 1 responds to the new anti-tampering regulations and makes it possible to clearly indicate whether the container 1 has already been opened or not.
Furthermore, the preceding advantage is obtained thanks to a contour wherein there is substantially only one main gluing point or, at most, two gluing points.
Therefore, the container 1 maintains a significant manufacturing simplicity and consequent cheapness.
The invention is susceptible of variants falling within the scope of the inventive concept defined by the claims.
In this context, all the details can be replaced by equivalent elements and the materials, shapes and dimensions can be any.

Claims

1. Container (1 ) for pharmaceutical product comprising:
- a casing (2) including:
- one or more first faces (20) defining a containment volume,
- at least one opening (21 ) capable of allowing access to said volume containment from the outside,
- at least one secondary face (22) overlapped, within said containment volume, to a portion of said first face (20) in such a way as to define an overlapping area (23) and a slot (24) arranged between said secondary face (22) and said first face (20), and
- at least one lid (3) configured to close said opening (21 ), in at least one closing configuration, and including at least a first portion (30) constrained to said casing (2) capable of overlapping said opening (21) and a second portion (31 ) configured to be housed within said slot (24) and to at least partially overlap said overlapping area (23) in said closing configuration, and characterized by that
- said portions (30, 31) are mutually constrained by connection means (32) which can be tear-off resolvable,
- said first face (20) comprises at least one flap (25) overlapped on part of said overlapping area (23) and protruding in skewed manner with respect to said first face (20) away from said opening (21), and
- said second portion (31 ) comprises a first hole (33) configured to house interlocked said flap (25) when said lid (3) is in a closing configuration in such a way as to irreversibly block said second portion (31 ) in said overlapping area (23) and allow access to said containment volume exclusively by resolving said connection means (32).
2. Container (1 ) according to claim 1 , wherein said secondary face (22) comprises a second hole (22a) overlapped on at least part of said flap (25) and configured to allow said flap (25) to protrude at least partially through said second hole (22a).
3. Container (1 ) according to any one of the preceding claims, wherein said connection means (32) comprise one or more first dashed incision lines (32a).
4. Container (1 ) according to any one of the preceding claims, wherein said connection means (32) comprise a second incision (32b) configured to perform a gripping portion (34) capable of allowing to quickly resolve said connection means (32).
5. Container (1 ) according to any one of the preceding claims, comprising two of said openings (21 ) and two of said lids (3) respectively configured to cover each of said openings (21 ), said openings (21) being arranged in correspondence of opposite sides of said casing (2).
6. Container (1 ) according to any one of the preceding claims, defining the shape of a rectangular parallelepiped wherein said lids (3) define the bases of said parallelepiped and said first faces (20) define the lateral surface of said parallelepiped.
7. Container (1 ) according to any one of the preceding claims, made from a contour (4) defining a main axis (1a) and including, in one piece, at least four first flat elements (40) constrained in succession along a longitudinal axis (1 b) perpendicular to said main axis (1a) and configured to form said casing (2) when closed, during assembly, around said main axis (1a) defining said first walls (21 ), and two fins ( 41 ) constrained to one of said first flat elements (40) on opposite sides of said flat element (40) with respect to said main axis (1a) and defining, during assembly phase, said lids (3).
8. Container (1 ) according to any one of the preceding claims, wherein said contour (4) comprises, in correspondence with a free end along said longitudinal axis (1a), a second flat element (42) configured to realize said secondary wall (22) when in assembly configuration and a bonding portion (43) arranged between said second flat element (42) and one of said first flat elements (40) and configured to be glued to one of said first flat elements (40).
9. Container (1 ) according to any one of the preceding claims, wherein said bonding portion (43) has a lower extension with respect to said first flat element (40) on which is constrained in such a manner that said first flat elements (40), said gluing portion (43) and said second flat element (42) define, when assembled, a substantially spiral section perpendicular to said main axis (1a).
10. Container (1 ) according to any one of the preceding claims, wherein said contour (4) comprises a fixing portion (44) disposed adjacent to free end of said second flat element (42) and configured to be glued to a said first flat element (40) on a side opposite to said bonding portion (43) in such a way as to realize said slot (24).
EP21701597.3A 2020-01-22 2021-01-20 Container for a pharmaceutical product Pending EP4093677A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102020000001186A IT202000001186A1 (en) 2020-01-22 2020-01-22 CONTAINER FOR PHARMACEUTICAL PRODUCT
PCT/IB2021/050396 WO2021148947A1 (en) 2020-01-22 2021-01-20 Container for a pharmaceutical product

Publications (1)

Publication Number Publication Date
EP4093677A1 true EP4093677A1 (en) 2022-11-30

Family

ID=70295860

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21701597.3A Pending EP4093677A1 (en) 2020-01-22 2021-01-20 Container for a pharmaceutical product

Country Status (3)

Country Link
EP (1) EP4093677A1 (en)
IT (1) IT202000001186A1 (en)
WO (1) WO2021148947A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023144555A1 (en) * 2022-01-28 2023-08-03 Duallok Limited Package and sleeve therefor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2428423B (en) * 2005-07-15 2008-12-10 Field Group Plc Child-resistant packaging
ITMI20071758A1 (en) * 2007-09-13 2009-03-14 Gi Bi Effe Srl BOX WITH INVIOLABLE WARRANTY SEAL
KR101294203B1 (en) * 2010-10-12 2013-08-16 주식회사 태신인팩 Paper box
EP2805895A1 (en) * 2013-05-23 2014-11-26 Krka Tovarna Zdravil, D.D., Novo Mesto Box having tamper-evident closure

Also Published As

Publication number Publication date
WO2021148947A1 (en) 2021-07-29
IT202000001186A1 (en) 2021-07-22

Similar Documents

Publication Publication Date Title
EP1893103B1 (en) Molded package
US4141449A (en) Recloseable pilfer-proof container and blanks
US4232816A (en) Clamshell type carton
US8006893B2 (en) Container having tab identifiers and method for constructing the same
US20070267468A1 (en) Container having tab identifiers and method for constructing the same
US20080217390A1 (en) Child-proof carton package
US4437570A (en) Shipping carton with case knife protection for inner cartons
US5366141A (en) Recloseable paperboard container with optional closure means
WO2021148947A1 (en) Container for a pharmaceutical product
US4129247A (en) Die-cut carton with built-in fillers
US4313540A (en) Carton with article retaining structure
FI64325B (en) HEXAGONAL LAODSTOMME
US3125258A (en) Dispensing container and blank therefor
US20120279961A1 (en) Dispensing container
US6874678B2 (en) Shipping and display container
US20200129376A1 (en) Pharmaceutical packaging
CN112119015A (en) Shipping box
US6892932B2 (en) Efficient food carton
US3807625A (en) Handled end load carton
US20220289425A1 (en) Child-resistant package
US20230016379A1 (en) Tamper-evident package, in particular child-proof package
US20210292041A1 (en) Tamper-evident paperboard food container
US4198900A (en) Method of making a recloseable, pilfer-proof container
EP4037982B1 (en) Pharmaceutical product container
EP3626642A1 (en) Tamper-proof packaging

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220705

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230602

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240404